Role of matrix metalloproteinase-9 in the pathogenesis of osteoporosis in patients with chronic obstructive pulmonary disease

Terapevticheskii Arkhiv

Volumn 84, Issue 8, 2012, Pages 37-40

  Kochetkova, E A ^a   Ugai, L G ^a   Maistrovskaya, Yu V ^a   Burya, K A ^a   Nevzorova, V A ^a  

^a PACIFIC STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Chronic obstructive pulmonary disease; Metalloproteinases; Osteoporosis; Tissue inhibitors of metalloproteinase; Tumor necrosis factor a

Indexed keywords

GELATINASE B; TIMP1 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PHYSIOLOGY;

FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OSTEOPOROSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84867973434     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Barnes P.J., Celli B.R. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165-1185.
2. Incalii R.A., Caradonna P., Ranieri P., et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 2000; 94:1079-1084.
3. Tschopp O., Schmid C, Speich R., et al. Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest 2006; 129:1002-1008.
4. Franco C.B., Paz-Filho G, Gomes P.E., et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporosis Int 2009; 20 (11): 1881-1887.
5. Engelen M.P.K.J, Schols A.M.W.J., Heidendal G.A.K., Wbuters E.F.M. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1998; 68:1298-1303. (Pubitemid 28550964)
6. Funada Y., Nishimura Y, Youkoyama M. Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice. Kobe J Med Sci 2004; 50: 59-67. (Pubitemid 41007603)
7. Greenlee K.L., Werb Z, Kheradman F. Matrix metalloproteinases in lung: multiple, multifarious and multifaceted. Physiol Rev 2007; 87: 69-98. (Pubitemid 46209991)
8. Anderson T.L., del Carem Ovejero M., Kirkegaard T., et al. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of M M Ps synthesized by other cells. Bone 2004; 35: 1107-1119. (Pubitemid 39487357)
9. Li Y, Zhang Zh., Xu Yo., et al. TNF-α Up-regulates Matrix Metalloproteinase- 9 Expression and Activity in Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease. J Huazhong University of Science and Technology 2006; 26:6: 647-650.
10. Bon J.M., Zhang Y., Duncan S.R., et al. Plasma inflammatory mediators associated with bone metabolism in COPD. COPD 2010;7:3:186-191.
11. Graat-Verboom L., Wouters E.F., Smeenk F.W. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34:1:209-218.
12. Vrieze A., Greef de H.M., Wykstra P.J., Wempe J.B. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporosis Int 2007; 18: 1197-1202. (Pubitemid 47300271)
13. Jorgensen N.R., Schwarz P., Holme I., et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease - A cross-sectional study. Respir Med 2006;4: 34-38.
14. Pinto-Plata V., Toso J., Lee K., et al. Profiling serum biomarkers in patients with COPD: associationswith clinical parameters. Thorax 2007; 62:595-601. (Pubitemid 47056886)
15. Aldonyte R., Jansson L., Pitulainen E, Janciauskiene S. Circulating monocytes from healthy individuals and COPD patients. Respir Res 2003;4:11-15.
16. Vignola A.M., Riccobono L., Mirabella A., et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158:6:1945-1950. (Pubitemid 29008837)
17. Chakrabarti S., Patel K.D. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 2005; 31:6: 599-621. (Pubitemid 40967244)
18. Bolton C.E, Stone M.D., Edwards PH., et al. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease. Chron Respir Dis 2009;6:81-87.
19. Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003; 28: 12-24. (Pubitemid 36017046)
20. Zhao H., Cai G, Du J., et al. Expression of Matrix Metalloproteinase-9 mRNA in Osteoporotic Bone Tissues. J Tongji Medical University 1997; 17:1:28-31.
21. Takabatake N., Nakamura H., Abe S., et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1179-1184. (Pubitemid 30243827)